Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL and ADACEL.

Abstract

Acellular pertussis-containing combination vaccines are widely used in the developed world for the control of pertussis and have been successful in controlling disease in preschool-aged children. Combination vaccines formulated for use in adolescents and adults have been developed more recently and are increasingly being implemented for the control of pertussis in these age groups. One such family of products is PENTACEL (Haemophilus influenzae type b conjugate vaccine reconstituted with component pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine, DTaP-IPV-Hib), for use in young children, and ADACEL (tetanus and diphtheria toxoids adsorbed combined with component pertussis vaccine, dTap) for use in adolescents and adults. These products have been demonstrated to be safe, immunogenic and effective for the control of pertussis and the other included diseases.

• Authors: Scott A Halperin
• Journal: Expert opinion on biological therapy (Expert Opin Biol Ther) Vol. 6 Issue 8 Pg. 807-21 (Aug 2006) ISSN: 1744-7682 [Electronic] England
• PMID: 16856802 (Publication Type: Journal Article, Review)

Chemical References

• Diphtheria-Tetanus-Pertussis Vaccine
• Diphtheria-Tetanus-acellular Pertussis Vaccines
• Haemophilus Vaccines
• Pertussis Vaccine
• Poliovirus Vaccine, Inactivated
• Vaccines, Combined
• adacel
• pentacel

Topics

• Adolescent
• Adult
• Age Factors
• Child
• Child, Preschool
• Clinical Trials as Topic
• Diphtheria-Tetanus-Pertussis Vaccine
• Diphtheria-Tetanus-acellular Pertussis Vaccines (therapeutic use)
• Haemophilus Vaccines
• Humans
• Infant
• Pertussis Vaccine (therapeutic use)
• Poliovirus Vaccine, Inactivated
• Vaccines, Combined (therapeutic use)
• Whooping Cough (epidemiology, prevention & control)